Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

Fri, 24th Aug 2018 08:38

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index Shire rose after getting approvals for a new drug, while Antofagasta benefited from a broker upgrade, as did FTSE 250-listed Ted Baker, in a fairly quiet morning for UK corporate news. The FTSE 100 was marginally higher, by 1.49 points, at 7,564.95 early Friday.The mid-cap FTSE 250 was down just 2.70 points at 20,661.89, while the AIM All-Share was 0.2% lower at 1,090.45The Cboe UK 100 was flat at 12,817.86, the Cboe UK 250 was up 0.1% at 18,781.25, and the Cboe UK Small Companies was also 0.1% higher at 12,336.55.The pound was higher against the dollar quoted at USD1.2837 Friday compared to USD1.2830 at close Thursday.Turning to UK company news early Friday, FTSE 100-listed biotechnology company Shire was 2.8% higher after the US Food & Drug Administration has approved its Takhzyro drug to treat a rare genetic disease.The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening.Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo.Also in the FTSE 100, miner Antofagasta was 2.3% higher as RBC raised it to an Outperform rating from Sector Perform. In the FTSE 250, energy firm Petrofac was 2.1% higher as it sold its 20% stake in the Greater Stella Area in the UK North Sea for USD292 million to Ithaca Energy, with the deal set to bring a USD55 million impairment charge.Chief Executive Ayman Asfari said: "This disposal marks a further milestone in our journey back to a capital-light business and, along with recently-agreed transactions in Mexico and Tunisia, marks the significant progress we are making on our stated strategy."Computacenter was 0.7% higher as it posted a 9.5% rise in statutory pretax profit for the six months to June to GBP52.0 million, while adjusted pretax profit was up 24% to GBP52.1 million.Revenue climbed to GBP2.01 billion, rising 18% year-on-year, going past the GBP2 billion mark for the first time.Computacenter's core Technology Sourcing division has done particularly well, increasing revenue by 26% to GBP1.43 billion, while Services rose 2.3% to GBP574.8 million.The company is paying an 8.7 pence per share interim dividend to its shareholders, higher than the 7.4p paid out for the same period last year.Computacenter has maintained guidance for 2018, which was upgraded in July, and though the second half of 2018 will be more difficult to predict due to a strong comparable the company said it is making "significant" progress.Retailer Ted Baker was 1.1% higher as Peel Hunt raised its rating for the stock to Add from Hold. Elsewhere, Kingspan was up 6.4% as it reported a 15% rise in interim revenue to EUR2.01 billion, passing EUR2 billion for the first time in a six-month period.Kingspan's pretax profit for the period was EUR177.6 million, up from EUR163.3 million a year prior.The company has lifted its interim dividend to 12.0 euro cents from the 11.0 cents paid for the first half of 2017.Kingspan said it was a record period, despite a slow start due to a bad winter, with the second quarter of 2018 particularly strong, a period in which revenue grew 21% year-on-year.The UK was "particularly robust", Kingspan said, despite ongoing uncertainty over Brexit. North American and German operations did well, the company added.Looking ahead, Kingspan said the good momentum in the second quarter has continued, and it expects strength in other geographies to offset any Brexit-related weakness in the UK.On AIM, Kefi Minerals was 16% higher as it signed a heads of agreement with investors in Ethiopia for between USD30 million and USD35 million for its Tulu Kapi gold project in the country. At the other end of the index was Bahamas Petroleum, down 73%, after a "major" international oil company decided not to extend an exclusivity agreement with Bahamas Petroleum.The company has now started looking for other third parties to discuss funding for its first exploration well. Later on Friday, at approximately 1500 BST, Federal Reserve Chairman Jerome Powell is expected to speak at Jackson Hole."Fed Chair Powell's speech at the Jackson Hole Economics Symposium will be the main focus in an otherwise relatively quiet day," said Lloyds Bank. "The symposium as a whole is an occasion for central bankers to meet with academics and discuss big economic issues. As such much of the discussion has little immediate impact on markets.""However, the Fed Chair's opening remarks usually cover the monetary policy outlook and occasionally the speech has been used to signal potential shifts in policy. Powell's remarks will therefore be followed closely," Lloyds continued.Elsewhere in US economic news, China's Ministry of Commerce said Friday it had held "constructive meetings" with officials from its American counterpart, despite the fact the summit failed to prevent a further escalation in tariffs.Chinese officials led by Vice Minister of Commerce & Deputy China International Trade Representative Wang Shouwen met with US Treasury officials on Wednesday and Thursday in Washington DC.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average 0.3% lower, the S&P 500 down 0.2%, and the Nasdaq Composite closing 0.1% lower. In China, the Shanghai Composite ended 0.2% higher.The Japanese Nikkei 225 index closed 0.8% higher on Friday, while the Hang Seng index in Hong Kong is down 0.3% in late tradeConsumer prices in Japan rose 0.8% year-on-year in July amid growing energy costs, but were still far off a 2% target set by the Bank of Japan more than five years ago, the government said Friday.The reading represented the 19th straight month of increase, according to the Ministry of Internal Affairs and Communications.The cost of kerosene jumped 22.2%, that of petrol climbed 16.8% and that of electricity 2.5%, the ministry said.The core consumer price index, which excludes fresh food, stood at 100.9 against a base of 100 for 2015, the ministry said.
More News
30 Nov 2018 07:38

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE is

Read more
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.